Zerodha-Backed Rainmatter Invests INR 10 Cr Each In Boson Whitewater, TruNativ

Zerodha-backed venture firm Rainmatter has reportedly invested INR 10 Cr in equity funding each into water recycling startup Boson Whitewater and nutrition-focused brand TruNativ.

Boson Whitewater focuses on converting surplus sewerage treatment plant (STP) water into potable water, addressing water scarcity issues in major cities like Bengaluru.

On the other hand, TruNativ, a direct-to-consumer (D2C) brand, offers nutritional products such as Everyday Protein, Everyday Fibre, and Everyday Sweetener, available through its own website and various ecommerce platforms.

Rainmatter is an early-stage venture firm that invests in startups across fintech, clean energy, climate tech, and healthtech. A few months ago, the firm invested about INR 58.25 Cr (around $7 Mn) in the agritech startup Two Brothers Organic Farms.

Zerodha also runs a not-for-profit arm named Rainmatter Foundation.

Speaking to ET, Dinesh Pai, head of Rainmatter, said, “Between 2016 and now, we have invested around INR 650 Cr into a wide range of startups across sectors.” He added, “Out of Nithin Kamath’s total commitment of INR 1,000 Cr announced last year, around INR 150 Cr has been deployed so far.”

Rainmatter participated in the recent $6.5 Mn funding round for space tech startup GalaxEye, investing INR 5 Cr across the initial and follow-up rounds. 

As per the report, the Bengaluru-based fund has invested in around 100 companies, including 31 fintech firms, 28 climate tech startups, and 21 in the health and nutrition sector.

Its fintech portfolio includes startups such as smallcase, Ditto and Digio, while its health and wellness portfolio counts names such as The Whole Truth, Peesafe, among others. In addition, it has also invested in climate tech startups such as Akshayakalpa, Solarsquare, Zerocircle, Ossus, among others. 

“We understand Indian startups need patient capital to build long-term businesses… We are not investing with an exit time frame in mind, we are patient capital available for startups wanting to build for India and the world with a long-term mindset,” Pai added in the report.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.